ViaDerma Inc (VDRM)

[Mistral]

6. Patents, trademarks, licenses, franchises, concessions, royalty agreements or labor contracts, including their
duration;

We currently have a non-exclusive license on U.S. patent application #20130190274, Topical Drug Delivery System with Dual Carriers. We licensed this patent from Dr. Phillips.

This is in the same Disclosure Statement uploaded 12.29.16 that states Viabecline is based on the patent owned by Phillips/Keough--#20130190274

http://www.otcmarkets.com/financialReportViewer?symbol=VDRM&id=164573

The excerpt below was in my last post and from the same disclosure.

A. Business Development:

ViaDerma, Inc’s lead product is an FDA registered topical antibiotic called Viabecline...The products are based on a patent pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.

Can you please show evidence that Phillips company has anything to do with Viabecline?